APPROVAL OF InSpec IPA – June 2019

Authorisation of Disinfectants to the Biocidal Products Regulation (BPR EU 528/2012)

The BPR is the legislation concerning the authorisation of biocides for use in the European Union (EU). It is Redditch Medical’s intention to ensure all InSpec biocides comply with the BPR and as a provider to such a critical marketplace we are fully committed to supporting all our products through this process.  This enables continued supply of InSpec™ Contamination Control range for use in Biopharma and Medical Device industries. Specifically, this covers Annex V, Main Group 1 Disinfectants, Pt2 Disinfectants and algaecides not intended for direct application to humans or animals.

Redditch Medical is pleased to be one off of the first disinfectant manufacturers to have IPA family authorisation granted according to Regulation 528/2012 of the European Parliament, Product Type 2.   InSpec IPA is approved for sale and for use as a biocidal product according to this product use authorisation.

Redditch Medical’s experience in registration processes has paid dividends in the process as an experienced high quality manufacturer regulated by numerous bodies.

Redditch Medical is now in receipt of the Product Authorisation Certificate from the UK Health and Safety Executive (HSE), Authorisation Number UK-2019-1197, R4BP3 Asset Reference Number UK-0016657-0000 Document Number 2019/92263.